L'Hôtel-Dieu de Québec
10, rue McMahon
0881
Québec, Québec
Canada G1R 2J6

Dernières nouvelles

Information non disponible

59 enregistrements « 1 de 6 »

Haider M, Ladurner C, Mayr R, Tandogdu Z, Fritsche HM, Fradet V, Comploj E, Pycha A, Lemire F, Lacombe L, Fradet Y, Toren P, Lodde M

Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series.

Article de revue

Urol Oncol, 37 (5), p. 300.e9-300.e15, 2019, ISSN: 1078-1439.

Résumé | Liens:

Fradet V, Toren P, Nguile-Makao M, Lodde M, Levesque J, Leger C, Caron A, Bergeron A, Ben-Zvi T, Lacombe L, Pouliot F, Tiguert R, Dujardin T, Fradet Y

Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.

Article de revue

BJU Int, 121 (3), p. 399-404, 2018, ISSN: 1464-4096.

Résumé | Liens:

Koziolek M, Beige J, Wallbach M, Zenker D, Henning G, Halbach M, Mader N, Mahfoud F, Schlieper G, Schwenger V, Hausberg M, Borgel J, Lodde M, van der Giet M, Muller-Ehmsen J, Passauer J, Parmentier S, Luders S, Kramer BK, Buttner S, Limbourg F, Jordan J, Vonend O, Predel HG, Reuter H

[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].

Article de revue

Internist (Berl), 58 (10), p. 1114-1123, 2017, ISSN: 0020-9554.

Résumé | Liens:

Simone G, De Nunzio C, Ferriero M, Cindolo L, Brookman-May S, Papalia R, Sperduti I, Collura D, Leonardo C, Anceschi U, Tuderti G, Misuraca L, Dalpiaz O, Hatzl S, Lodde M, Trenti E, Pastore AL, Palleschi G, Lotrecchiano G, Salzano L, Carbone A, De Cobelli O, Tubaro A, Schips L, Zigeuner R, Tostain J, May M, Guaglianone S, Muto G, Gallucci M

Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset.

Article de revue

Eur J Surg Oncol, 42 (11), p. 1729-1735, 2016, ISSN: 0748-7983.

Résumé | Liens:

Veccia A, Caffo O, De Giorgi U, Di Lorenzo G, Ortega C, Scognamiglio F, Aieta M, Facchini G, Mansueto G, Mattioli R, Procopio G, Zagonel V, D'Angelo A, Spizzo G, Bortolus R, Donini M, Lo Re G, Massari F, Vicario G, Zucali PA, Alesini D, Bonetti A, Mucciarini C, Nicodemo M, Berruti A, Fratino L, Lodde M, Messina C, Perin A, Santini D, Sava T, Tucci M, Basso U, Maines F, Burgio LS, Galligioni E

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.

Article de revue

Future Oncol, 12 (4), p. 493-502, 2016, ISSN: 1479-6694.

Résumé | Liens:

Trama A, Botta L, Nicolai N, Rossi PG, Contiero P, Fusco M, Lodde M, Pannozzo F, Piffer S, Puppo A, Seeber A, Tumino R, Valdagni R, Gatta G, Prostate Cancer High Resolution Study Working Group

Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study.

Article de revue

Eur J Cancer, 67 , p. 91-98, 2016, ISSN: 0959-8049.

Résumé | Liens:

Gierth M, Mayr R, Aziz A, Krieger S, Wullich B, Pycha A, Lodde M, Salvadori U, Brundl J, Fritsche HM, Hofstadter F, Pawlik MT, Otto W, May M, Burger M, Denzinger S

Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.

Article de revue

J Cancer Res Clin Oncol, 141 (10), p. 1819-26, 2015, ISSN: 0171-5216.

Résumé | Liens:

Comai A, Trenti M, Mayr R, Pycha A, Bonatti G, Lodde M

Computed tomography after nephron-sparing surgery.

Article de revue

Abdom Imaging, 40 (7), p. 2424-31, 2015, ISSN: 0942-8925.

Résumé | Liens:

Caffo O, Ortega C, Di Lorenzo G, Sava T, De Giorgi U, Cavaliere C, Macrini S, Spizzo G, Aieta M, Messina C, Tucci M, Lodde M, Mansueto G, Zucali PA, Alesini D, D'Angelo A, Massari F, Morelli F, Procopio G, Ratta R, Fratino L, Lo Re G, Pegoraro MC, Zustovich F, Vicario G, Ruatta F, Federico P, La Russa F, Burgio SL, Maines F, Veccia A, Galligioni E

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger.

Article de revue

Urol Oncol, 33 (6), p. 265.e15-21, 2015, ISSN: 1078-1439.

Résumé | Liens:

Caffo O, Lo Re G, Sava T, Buti S, Sacco C, Basso U, Zustovich F, Lodde M, Perin A, Facchini G, Veccia A, Maines F, Barile C, Fratino L, Gernone A, De Vivo R, Pappagallo GL, Galligioni E

Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.

Article de revue

Future Oncol, 11 (6), p. 965-73, 2015, ISSN: 1479-6694.

Résumé | Liens:

59 enregistrements « 1 de 6 »
Signaler des modifications

Projets actifs

  • Centre hospitalier universitaire de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, du 2017-01-01 au 2099-12-31
Information provenant du registre des projets de recherche de l'Université Laval